Altered vessel signalling molecules in subjects with Downs syndrome

Area of Science:

• Biochemistry
• Immunology
• Genetics

Background:

• Downs syndrome (DS), the most common human chromosomal abnormality, is associated with intellectual disability.
• Emerging evidence suggests potential alterations in inflammatory molecule levels in individuals with DS.

Purpose of the Study:

• To investigate plasma levels of specific proinflammatory and vasoactive molecules in non-demented individuals with Downs syndrome.
• To explore age-related differences and correlations among these molecules in DS.

Main Methods:

• Plasma concentrations of interleukin-6 (IL-6), vascular endothelial growth factor (VEGF), monocyte chemoattractant protein-1 (MCP-1), and C-reactive protein (CRP) were quantified.
• Measurements were performed across pediatric, adult, and elderly age groups of subjects with DS.

Main Results:

• Individuals with DS exhibited increased plasma levels of IL-6 and MCP-1.
• Elevated VEGF levels were observed specifically in adult DS subjects.
• A positive linear correlation was found between IL-6 and MCP-1 levels, while neopterin and CRP remained within normal ranges, indicating no subclinical inflammation.

Conclusions:

• Altered regulation of IL-6 and MCP-1 in Downs syndrome may influence cognitive processes.
• These findings highlight specific molecular changes in DS that warrant further investigation for potential therapeutic targets.